Tiotropium might improve survival in subjects with COPD at high risk of mortality

BACKGROUND: Inhaled therapies reduce risk of chronic obstructive pulmonary disease (COPD) exacerbations, but their effect on mortality is less well established. We hypothesized that heterogeneity in baseline mortality risk influenced the results of drug trials assessing mortality in COPD. METHODS: T...

Descripción completa

Detalles Bibliográficos
Autores principales: Burgel, Pierre-Régis, Paillasseur, Jean-Louis, Dusser, Daniel, Roche, Nicolas, Liu, Dacheng, Liu, Yufeng, Furtwaengler, Armin, Metzdorf, Norbert, Decramer, Marc
Formato: Online Artículo Texto
Lenguaje:English
Publicado: BioMed Central 2014
Materias:
Research
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061116/
https://www.ncbi.nlm.nih.gov/pubmed/24913266
http://dx.doi.org/10.1186/1465-9921-15-64

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC4061116/
https://www.ncbi.nlm.nih.gov/pubmed/24913266
http://dx.doi.org/10.1186/1465-9921-15-64

Ejemplares similares